HPPI

HedgePath Pharmaceuticals, Inc.

 
Common Stock SEC Reporting - Current
OTCQX U.S.
Verified Company Profile 5/10/2017
Contact Info
  • 324 South Hyde Park Avenue
  • Suite 350
  • Tampa, FL 33606

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001042418
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: DE, USA
Year of Inc. 2013
Employees 3 a/o Jan 01, 2017
Company Officers/Contacts
Nicholas Virca CEO, President
Garrison J. Hasara CFO, Treasurer
James McNulty Secretary, Compliance Officer
Company Directors
E. Brendan Magrab Chairman
Stefan Cross Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Robert D Martin Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Dana Ono Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
W. Mark Watson Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Service Providers
Accounting/Auditing Firm
Cherry Bekaert LLP
401 East Jackson St
Suite 3400
Tampa, FL, 33602
United States
 
Securities Counsel
Ellenoff Grossman & Schole LLP OTCQX Sponsor
1345 Avenue of the Americas
New York, NY, 10105
United States
 
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Ellenoff Grossman & Schole LLP on 12/07/2016
  • Formerly=Commonwealth Biotechnologies, Inc. until 8-2013
HPPI Security Details
Share Structure
Market Value1 $111,064,579 a/o Jun 23, 2017
Authorized Shares 500,000,000 a/o Nov 16, 2016
Outstanding Shares 369,599,266 a/o Apr 27, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 58,569,902 a/o Apr 27, 2017
Par Value No Par Value
Shareholders
Shareholders of Record 54 a/o Apr 27, 2017
Short Selling Data
Short Interest 2,530 (-53.42%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security